Literature DB >> 1914494

Roles of UDP-glucuronosyltransferases in chemical carcinogenesis.

K W Bock1.   

Abstract

UDP-glucuronosyltransferases (UGT) play a major role in the elimination of nucleophilic metabolites of carcinogens, such as phenols and quinols of polycyclic aromatic hydrocarbons. In this way they prevent their further oxidation to electrophiles, which may react with DNA, RNA, and protein. They also inactivate carcinogenic, N-oxidized metabolites of aromatic amines. Furthermore, glucuronides may be stable transport forms of proximate carcinogens excreted via the biliary or urinary tract, thereby liberating the ultimate carcinogen at the target of carcinogenicity. Isozymes of the UGT enzyme superfamily that control the glucuronidation of metabolites of aromatic hydrocarbons and of N-oxidized aromatic amines have been identified in rats and humans. Phenol UGT appears to be coinduced with other drug-metabolizing enzymes via the Ah or dioxin receptor. This isozyme probably controls various proximate carcinogens and contributes to the persistently altered enzyme pattern, leading to the "toxin-resistance phenotype" at cancer prestages. Knowledge about UGTs in different species, their regulation, and their tissue distribution will improve the risk assessment of carcinogens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1914494     DOI: 10.3109/10409239109081125

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  12 in total

1.  Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer.

Authors:  Wei Tang; Yi-Ping Fu; Jonine D Figueroa; Núria Malats; Montserrat Garcia-Closas; Nilanjan Chatterjee; Manolis Kogevinas; Dalsu Baris; Michael Thun; Jennifer L Hall; Immaculata De Vivo; Demetrius Albanes; Patricia Porter-Gill; Mark P Purdue; Laurie Burdett; Luyang Liu; Amy Hutchinson; Timothy Myers; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina Garcia-Closas; Josep Lloreta; Alison Johnson; Molly Schwenn; Margaret R Karagas; Alan Schned; Amanda Black; Eric J Jacobs; W Ryan Diver; Susan M Gapstur; Jarmo Virtamo; David J Hunter; Joseph F Fraumeni; Stephen J Chanock; Debra T Silverman; Nathaniel Rothman; Ludmila Prokunina-Olsson
Journal:  Hum Mol Genet       Date:  2012-01-06       Impact factor: 6.150

2.  Cytosylglucuronic acid synthase (cytosine: UDP-glucuronosyltransferase) from Streptomyces griseochromogenes, the first prokaryotic UDP-glucuronosyltransferase.

Authors:  S J Gould; J Guo
Journal:  J Bacteriol       Date:  1994-03       Impact factor: 3.490

3.  The in vitro biosynthesis and stability measurement with agyl-glycuronide isoformes of the main metabolite of ipriflavone.

Authors:  K Jemnitz; F Lévai; K Monostory; I Szatmári; L Vereczkey
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Jul-Dec       Impact factor: 2.441

4.  Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.

Authors:  C P Strassburg; A Strassburg; N Nguyen; Q Li; M P Manns; R H Tukey
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

5.  Dietary Dihydromethysticin Increases Glucuronidation of 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol in A/J Mice, Potentially Enhancing Its Detoxification.

Authors:  Sreekanth C Narayanapillai; Linda B von Weymarn; Steven G Carmella; Pablo Leitzman; Jordan Paladino; Pramod Upadhyaya; Stephen S Hecht; Sharon E Murphy; Chengguo Xing
Journal:  Drug Metab Dispos       Date:  2016-01-07       Impact factor: 3.922

6.  Isolation and characterization of the monkey UGT2B30 gene that encodes a uridine diphosphate-glucuronosyltransferase enzyme active on mineralocorticoid, glucocorticoid, androgen and oestrogen hormones.

Authors:  Caroline Girard; Olivier Barbier; David Turgeon; Alain Bélanger
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

Review 7.  Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.

Authors:  H K Kroemer; U Klotz
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

Review 8.  Does glutathione S-transferase Pi (GST-Pi) a marker protein for cancer?

Authors:  S Aliya; P Reddanna; K Thyagaraju
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

Review 9.  Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen.

Authors:  Philip Lazarus; Andrea S Blevins-Primeau; Yan Zheng; Dongxiao Sun
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

Review 10.  Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis.

Authors:  R L Melnick; M C Kohn; C J Portier
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.